Posted on June 9, 20266/9/26
EVERSANA Strengthens Commitment to Driving Market Access Growth with Addition of Industry Expert Jen Norton
Recent Press Releases
Posted on May 6, 20265/6/26
EVERSANA Appoints Agency and Commercialization Veteran Mike Guarino to Lead Global Agency EVERSANA INTOUCH
Posted on April 27, 20264/27/26
Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.
Posted on February 11, 20262/11/26
EVERSANA Names Monica Avram Executive Vice President and Chief Legal Officer to Advance Governance, Compliance, and Enterprise Growth
Posted on November 6, 202511/6/25
EVERSANA Named AI Company of the Year by BioTech Breakthrough
Posted on October 23, 202510/23/25
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE® (lamotrigine) Oral Suspension
Posted on October 16, 202510/16/25
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
Posted on September 11, 20259/11/25
EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS
Posted on August 26, 20258/26/25
EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
Posted on August 4, 20258/4/25